QUOIN PHARMACEUTICALS, LTD.

Analyst Reco. Quoin Pharmaceuticals, Ltd.

Equities

QNRX

US74907L4095

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 14/07/2025 BST			5-day change	1st Jan Change
9.050 ^USD	+1.80%		+1.91%	-60.26%

07-08	Quoin Pharmaceuticals & CFO Gordon Dunn agree to a mutual separation	RE
07-08	Quoin Pharmaceuticals Ltd. Announces Mutual Separation with CFO Gordon Dunn	CI

Analyst Reco.

Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating	15/03/24	MT
JMP Securities Lowers Quoin Pharmaceuticals' Price Target to $6 From $15, Maintains Market Outperform Rating	10/03/23	MT
Ladenburg Thalmann Downgrades Quoin Pharmaceuticals to Neutral From Buy	10/03/23	MT
Alliance Global Partners Initiates Coverage on Quoin Pharmaceuticals With Buy Rating, $20 Price Target	07/09/22	MT
Ladenburg Lowers Quoin Pharmaceuticals' Price Target to $12 From $25, Maintains Buy Rating	23/08/22	MT
JMP Securities Lowers Quoin Pharmaceuticals' Price Target to $15 From $100, Maintains Outperform Rating	19/08/22	MT
Maxim Lowers Price Target for Quoin Pharmaceuticals to $10 From $25, Maintains Buy Rating	18/08/22	MT
Ladenburg Thalmann Starts Quoin Pharmaceuticals at Buy With $2 Price Target	06/05/22	MT
Maxim Starts Quoin Pharmaceuticals at Buy with $5 Price Target	07/01/22	MT
JMP Securities Starts Quoin Pharmaceuticals at Market Outperform With $8 Price Target	15/12/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

Replicate our performance